NLRP3-directed antisense oligonucleotides reduce microglial immunoactivities in vitro.
Journal of neurochemistry
View this publicationJournal of neurochemistry
View this publicationJournal of clinical medicine
View this publicationCardiovascular research
View this publicationFrontiers in immunology
View this publicationBiomedicines
View this publicationNature reviews bioengineering
View this publicationCritical care (London, England)
View this publicationFrontiers in immunology
View this publicationNeuron
View this publicationEuropean heart journal. Digital health
View this publication